YUHSpace

BROWSE

Export

Cited 0 times in

Letter to the Editor regarding 'Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study' by Moik F, Riedl JM, and Ay C

DC Field Value Language
dc.contributor.author조병철-
dc.date.accessioned2024-10-04T02:43:26Z-
dc.date.available2024-10-04T02:43:26Z-
dc.date.issued2024-03-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/200572-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleLetter to the Editor regarding 'Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study' by Moik F, Riedl JM, and Ay C-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorA Passaro-
dc.contributor.googleauthorJ Wang-
dc.contributor.googleauthorS Shah-
dc.contributor.googleauthorJ M Bauml-
dc.contributor.googleauthorR G Campelo-
dc.contributor.googleauthorB C Cho-
dc.identifier.doi38029840-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.pmid10.1016/j.annonc.2023.11.012-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753423050810-
dc.subject.keywordAcrylamides*-
dc.subject.keywordAniline Compounds / therapeutic use-
dc.subject.keywordAntibodies, Bispecific*-
dc.subject.keywordCarcinoma, Non-Small-Cell Lung* / drug therapy-
dc.subject.keywordCarcinoma, Non-Small-Cell Lung* / genetics-
dc.subject.keywordDisease Progression-
dc.subject.keywordErbB Receptors / genetics-
dc.subject.keywordHumans-
dc.subject.keywordIndoles*-
dc.subject.keywordLung Neoplasms* / drug therapy-
dc.subject.keywordLung Neoplasms* / genetics-
dc.subject.keywordMorpholines*-
dc.subject.keywordMutation-
dc.subject.keywordProtein Kinase Inhibitors / therapeutic use-
dc.subject.keywordPyrazoles*-
dc.subject.keywordPyrimidines*-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume35-
dc.citation.number3-
dc.citation.startPage328-
dc.citation.endPage329-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.35(3) : 328-329, 2024-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links